T3 Defense Inc. (DFNS) · Oct 23, 2026 · Delisting
Nasdaq compliance pending — Pro forma stockholders’ equity ~$99.9M vs. $10M requirement
T3 Defense’s Nasdaq compliance update shows equity restored after warrant exercises, but the exchange has not yet confirmed the deficiency is resolved.
T3 Defense is building a defense-focused holding company that acquires and scales mission-critical aerospace and defense businesses, including capabilities around defense AI, simulation, navigation, drones, and rugged field infrastructure. This filing removes a listing overhang created by accounting mechanics, not operating weakness. Nasdaq’s August 20 notice was triggered after the February warrant financing was classified as a liability and its fair value rose sharply, pushing reported equity from approximately $42.5 million at March 31, 2026 to a deficit of approximately $19.7 million at June 30.
| Metric | Filing figure | Comparison / implication |
|---|---|---|
| Nasdaq minimum stockholders’ equity | $10.0M | Continued-listing requirement (Nasdaq compliance disclosure) |
| Warrant liability at June 30, 2026 | ~$124.4M | Down to a de minimis residual after exercises (Nasdaq compliance disclosure) |
| Warrants exercised by September 30, 2026 | ~96% | Removes the liability that drove the equity deficit (Nasdaq compliance disclosure) |
| Pro forma stockholders’ equity | ~$99.9M | About $89.9M above the Nasdaq threshold (Nasdaq compliance disclosure) |
The capital-structure problem is substantially repaired. Approximately 96% of the outstanding warrants had already been exercised by September 30, eliminating almost all of the non-cash liability and lifting pro forma equity to roughly $99.9 million. 〔0〕 That is a meaningful improvement versus the standing assumption that the Nasdaq deficiency remained unresolved, although it reflects warrant exercises and resulting capitalization rather than a demonstrated improvement in the defense businesses themselves.
The filing asks for clearance; it does not provide it. Management says it believes compliance has been regained and has requested that Nasdaq resolve the deficiency, but the exchange has not yet confirmed that conclusion. 〔1〕 Nasdaq will reassess the company using its next quarterly report, and the filing explicitly leaves open additional conditions, monitoring, or an adverse determination.
Bottom line: This materially improves T3 Defense’s immediate Nasdaq-listing position and removes the accounting-driven equity deficit from the story, but the outcome remains provisional until Nasdaq reviews the September 30, 2026 financials and confirms compliance.
September 30 10-Q and Nasdaq determination
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!